These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22484047)

  • 1. Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.
    Demento SL; Cui W; Criscione JM; Stern E; Tulipan J; Kaech SM; Fahmy TM
    Biomaterials; 2012 Jun; 33(19):4957-64. PubMed ID: 22484047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.
    Hamdy S; Haddadi A; Shayeganpour A; Samuel J; Lavasanifar A
    Pharm Res; 2011 Sep; 28(9):2288-301. PubMed ID: 21560020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
    San Román B; Gómez S; Irache JM; Espuelas S
    J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
    Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
    J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.
    Diwan M; Elamanchili P; Cao M; Samuel J
    Curr Drug Deliv; 2004 Oct; 1(4):405-12. PubMed ID: 16305402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2017 Feb; 111():33-43. PubMed ID: 27865932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.
    Hanson MC; Bershteyn A; Crespo MP; Irvine DJ
    Biomacromolecules; 2014 Jul; 15(7):2475-81. PubMed ID: 24894061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of antigen-loaded biodegradable nanoparticles and uptake by dendritic cells.
    Joshi VB; Geary SM; Salem AK
    Methods Mol Biol; 2014; 1139():453-66. PubMed ID: 24619699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
    Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs.
    Dhakal S; Hiremath J; Bondra K; Lakshmanappa YS; Shyu DL; Ouyang K; Kang KI; Binjawadagi B; Goodman J; Tabynov K; Krakowka S; Narasimhan B; Lee CW; Renukaradhya GJ
    J Control Release; 2017 Feb; 247():194-205. PubMed ID: 28057521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11.
    Santos DM; Carneiro MW; de Moura TR; Fukutani K; Clarencio J; Soto M; Espuelas S; Brodskyn C; Barral A; Barral-Netto M; de Oliveira CI
    Int J Nanomedicine; 2012; 7():2115-27. PubMed ID: 22619548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4
    Sahu R; Dixit S; Verma R; Duncan SA; Coats MT; Giambartolomei GH; Singh SR; Dennis VA
    Nanomedicine; 2020 Oct; 29():102257. PubMed ID: 32610072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
    Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
    PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble
    Margaroni M; Agallou M; Athanasiou E; Kammona O; Kiparissides C; Gaitanaki C; Karagouni E
    Int J Nanomedicine; 2017; 12():6169-6184. PubMed ID: 28883727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.